Company intelligence / Profile preview
Hualan Biological Vaccine Inc.
Xinxiang, Henan, Chinacphi-online.com ↗
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Commercial
01
Overview
Hualan Biological Vaccine Inc. has a strong commercial presence with multiple approved human vaccines targeting influenza (including the world’s first marketed H1N1 split virion vaccine), hepatitis B (recombinant), meningococcus groups A/C/Y/W135 polysaccharide vaccines, rabies vaccine and others. The company’s recombinant hepatitis B vaccine has demonstrated safety and immunogenicity in clinical trials for infants/children. Products comply with international cGMP standards and have been distributed to over forty countries worldwide.[5][6][7][10]
- Therapeutic areas
- CardiovascularNeurologyInfectious Diseases
- Modalities
- Vaccines (bacterial and viral, including recombinant protein subunit vaccines)Genetic engineering vaccines
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
Request access →03
Partnerships
Strategic partnerships with governmental/non-governmental organizations for vaccination programs globally.[5] No specific pharma co-development partners named.
Beyond the preview
Go deeper on Hualan Biological Vaccine Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hualan Biological Vaccine Inc..